NCT01394367

Brief Summary

Aim of this study is to investigate whether and to what extent a cautious respiratory and exercise therapy can complement medical treatment and change the condition, oxygen uptake, quality of life, the pulmonary vascular pressures, the size of the right heart and the 6-minute walk distance in patients with pulmonary hypertension.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2010

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2010

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 28, 2011

Completed
16 days until next milestone

First Posted

Study publicly available on registry

July 14, 2011

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2015

Completed
Last Updated

December 23, 2019

Status Verified

December 1, 2019

Enrollment Period

4.9 years

First QC Date

June 28, 2011

Last Update Submit

December 19, 2019

Conditions

Keywords

respiratory therapyexercise therapyoxygen uptakequality of liferight ventricular functionsevere pulmonary hypertension

Outcome Measures

Primary Outcomes (1)

  • Improvement of peak O2 uptake (VO2peak) under stress

    Three-week inpatient rehabilitation, continuation of the training program for another 12 weeks at home (exercise group), patients in the control group continued their usual activities. After 15 weeks, training is also offered to patients in the control group.

    up to 15 weeks

Secondary Outcomes (1)

  • Changes in hemodynamics at rest and during exercise

    up to 15 weeks

Study Arms (2)

Respiratory and exercise therapy

EXPERIMENTAL

Randomized, prospective, controlled, blinded study of three-week inpatient rehabilitation and subsequent continuing of the training at home for 12 weeks. The control group received conventional rehabilitation without a specific training program. After 15 weeks training is also offered to patients in the control group.

Other: respiratory and exercise therapy

respiratory and exercise therapy

NO INTERVENTION

Interventions

Conventional therapy with diet, massage, relaxation baths, plus easy strolls specific respiratory and physical therapy plus mental walking training

Respiratory and exercise therapy

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Consent form
  • men and women\> 18 years \<75 years
  • invasively confirmed chronic PH who have received complete diagnostic evaluation by specialized doctors / physicians according to the WHO classification at a center for pulmonary hypertension and were adjusted for 2 months under intensive medical therapy and are stable.

You may not qualify if:

  • Pregnancy or lactation
  • Change in medication during the last 2 months
  • Patients with signs of right heart decompensation
  • severe walking disturbance
  • uncertain diagnoses
  • No previous invasively confirmation of PH
  • acute diseases, infections, fever
  • Serious lung disease with FEV1 \<50% or TLC \<70% of target

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for pulmonary Hypertension, Thoraxclinic Heidelberg

Heidelberg, 69126, Germany

Location

MeSH Terms

Conditions

Hypertension, Pulmonary

Interventions

Respiratory RateExercise Therapy

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Vital SignsPhysical ExaminationDiagnostic Techniques and ProceduresDiagnosisRespirationRespiratory Physiological PhenomenaCirculatory and Respiratory Physiological PhenomenaRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Ekkehard Grünig, Professor

    Center for pulmonary hypertension, Thoraxclinic Heidelberg

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. med. Ekkehard Grünig

Study Record Dates

First Submitted

June 28, 2011

First Posted

July 14, 2011

Study Start

June 1, 2010

Primary Completion

May 1, 2015

Study Completion

May 1, 2015

Last Updated

December 23, 2019

Record last verified: 2019-12

Locations